ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01395004
Recruitment Status : Completed
First Posted : July 15, 2011
Last Update Posted : November 6, 2017
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2013
  Actual Study Completion Date : November 2013